Skip to content

The effects of PEG tube feeding of semi-solid nutrients on salivation

The effects of PEG tube feeding of semi-solid nutrients on salivation - The effects of PEG tube feeding of semi-solid nutrients on salivation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006732
Enrollment
10
Registered
2011-11-15
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aspiration pneumonia

Interventions

Administration of liquid nutrients for 7 days followed by semi-solid nutrients for 7 days Administration of semi-solid nutrients for 7 days followed by solid nutrients for 7 days

Sponsors

Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Lead Sponsor
Nishi Kyoto Hospital Intensive Care Home for the Elderly ,Yorokobien
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)At least 2 weeks have passed after gastrostomy. (2)Patients required tube-feeding in hospital setting (3)Patients with correctable dehydration by the time of enrollment if they have. (4)Patients over 20 years-old and who have given written informed consent by themselves or their representative (5)Regardless of gender

Exclusion criteria

Exclusion criteria: (1) Patients with diseases that affect salivation such as Sjogren's syndrome, sialoadenitis, salivary gland cancer (2) Patients with remarkably decreased salivation(patients with less than 0.05g in 30 seconds assessed by the cotton methods) (3) Patients with severe infection of gastrostomy site (4) Patients with active aspiration pneumonitis (5) Patients who can take food orally (6) Patients with ileus or no residual intestinal function (7) Patients who have not undergone neither oral feeding nor tube feeding over 30 days (8) Patients with severe liver disorder(AST or ALT 2.5 times higher than upper normal limit of the institution) (9) Patients with poor control of diabetes mellitus(HbA1C > 8.0%) (10) Patients with renal dysfunction(Cre > 2.0mg/dl) (11) Patients with allergy to any ingredients of the enteral formula (12) Patients who were judged as inappropriate to enroll clinical study by physicians

Design outcomes

Primary

MeasureTime frame
To compare the change of salivary secretion after administration of liquid or semi-solid enteral nurtients

Secondary

MeasureTime frame
To measure pH of saliva and to evaluate status of gastroesophageal reflux

Countries

Japan

Contacts

Public ContactManabu Ishitoko,M.D.

Kitano Hospital, The Tazuke Kofukai Medical Research Institute Respiratory Disease Center

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026